Articles dans des revues avec comité de lecture (165)
  1. 126. Decrem, Y., Mariller, M., Lahaye, K., Blasioli, V., Beaufays, J., Zouaoui Boudjeltia, K., Vanhaeverbeek, M., Cérutti, M., Brossard, M., Vanhamme, L., & Godfroid, E. (2008). The impact of gene knock-down and vaccination against salivary metalloproteases on blood feeding and egg laying by Ixodes ricinus. International Journal for Parasitology, 38(5), 549-560. doi:10.1016/j.ijpara.2007.09.003
  2. 127. Van Antwerpen, P., Moreau, P., Zouaoui Boudjeltia, K., Babar, S., Dufrasne, F., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2008). Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme. Talanta, 75(2), 503-510. doi:10.1016/j.talanta.2007.11.040
  3. 128. Van Antwerpen, P., Prévost, M., Zouaoui Boudjeltia, K., Babar, S., Legssyer, I., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., Neve, J., & Dufrasne, F. (2008). Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification. Bioorganic & medicinal chemistry, 16(4), 1702-1720. doi:10.1016/j.bmc.2007.11.025
  4. 129. Zouaoui Boudjeltia, K., Brohée, D., Piro, P., Nuyens, V., Ducobu, J., Kherkofs, M., Van Antwerpen, P., Cauchie, P., Remacle, C., & Vanhaeverbeek, M. (2008). Monocyte-platelet complexes on CD14/CD16 monocyte subsets: relationship with ApoA-I levels. A preliminary study. Cardiovascular pathology, 17(5), 285-288. doi:10.1016/j.carpath.2007.10.004
  5. 130. Zouaoui Boudjeltia, K., Faraut, B., Stenuit, P., Esposito, M. J., Dyzma, M., Brohée, D., Ducobu, J., Vanhaeverbeek, M., & Kerkhofs, M. (2008). Sleep restriction increases white blood cells, mainly neutrophil count, in young healthy men: A pilot study. Vascular health and risk management, 4(6), 1467-1470.
  6. 131. Zouaoui Boudjeltia, K. (2008). La médecine arabo-musulmane et son enseignement aux siècles d'or, l'exemple d'al-Râzî, l'un de ses meilleurs représentants! Revue médicale de Bruxelles, 29(2), 137-143.
  7. 132. Kohnen, S. S., Franck, T., Van Antwerpen, P., Zouaoui Boudjeltia, K., Mouithys-Mickalad, A., Deby, C. C., Moguilevsky, N., Deby-Dupont, G., Lamy, M., & Serteyn, D. (2007). Resveratrol inhibits the activity of equine neutrophil myeloperoxidase by a direct interaction with the enzyme. Journal of agricultural and food chemistry, 55(20), 8080-8087. doi:10.1021/jf071741n
  8. 133. Van Antwerpen, P., Dufrasne, F., Lequeux, M., Zouaoui Boudjeltia, K., Lessgyer, I., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2007). Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid. European journal of pharmacology, 570(1-3), 235-243. doi:10.1016/j.ejphar.2007.05.057
  9. 134. Piagnerelli, M., Zouaoui Boudjeltia, K., Gulbis, B., Vanhaeverbeek, M., & Vincent, J. L. (2007). Anemia in sepsis: the importance of red blood cell membrane changes. TATM. Transfusion alternatives in tranfusion medicine, 9(3), 143-149. doi:10.1111/j.1778-428X.2007.00072.x
  10. 135. Piagnerelli, M., Zouaoui Boudjeltia, K., Brohée, D., Vereerstraeten, A., Piro, P., Vincent, J. L., & Vanhaeverbeek, M. (2007). Assessment of erythrocyte shape by flow cytometry techniques. Journal of Clinical Pathology, 60(5), 549-554. doi:10.1136/jcp.2006.037523
  11. 136. Kerkhofs, M., Zouaoui Boudjeltia, K., Stenuit, P., Brohée, D., Cauchie, P., & Vanhaeverbeek, M. (2007). Sleep restriction increases blood neutrophils, total cholesterol and low density lipoprotein cholesterol in postmenopausal women: A preliminary study. Maturitas, 56(2), 212-215. doi:10.1016/j.maturitas.2006.07.007
  12. 137. Van Antwerpen, P., Neve, J., Moreau, P., Zouaoui Boudjeltia, K., Vanhaeverbeek, M., Prévost, M., Babar, S., Legssyer, I., Moguilevsky, N., & Ducobu, J. (2007). Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis. Journal of cardiovascular pharmacology, 50, 350-351.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>